Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04880070 · ClinicalTrials.gov registry record · NA
Post-Market Clinical Follow Up Study to Collect Additional Data and Imaging
A NA study of Connective Tissue Defect, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT04880070 is a NA study of Connective Tissue Defect that has completed, run by Cynosure. The registered enrollment target is 5 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04880070, a NA study of Connective Tissue Defect, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, open label, multi-center clinical study to collect additional data and imaging for the ViaSure device.The intended use of the ViaSure device used in this study is to assess the usability and tissue response to shock wave treatment.
Conditions Studied
Interventions
- DEVICE Shockwave Treatment
Study Locations (1)
Massachusetts
- Cynosure, Inc. - Westford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-03-12 |
| Est. Completion | 2021-05-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04880070
The ClinicalTrials.gov registry entry for NCT04880070 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cynosure, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Connective Tissue Defect appearing as the primary indexed condition, and to 1 intervention - of which Shockwave Treatment is the first listed.
NCT04880070 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04880070 about?
NCT04880070 is a clinical study titled "Post-Market Clinical Follow Up Study to Collect Additional Data and Imaging". This is a prospective, open label, multi-center clinical study to collect additional data and imaging for the ViaSure device.The intended use of the ViaSure device used in this study is to assess the usability and tissue response to shock wave treatment.
What is the current status of trial NCT04880070?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2021-03-12. Estimated completion is 2021-05-11.
What conditions does trial NCT04880070 study?
This clinical trial studies the following conditions: Connective Tissue Defect.
What interventions are being tested in trial NCT04880070?
The interventions under investigation include: Shockwave Treatment (DEVICE).
Who is sponsoring clinical trial NCT04880070?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04880070 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.